Long-term outcomes following infection of cardiac implantable electronic devices: A prospective matched cohort study

Heart

Volumn 98, Issue 9, 2012, Pages 724-731

  Deharo, Jean Claude ^a   Quatre, Amandine ^a   Mancini, Julien ^a   Khairy, Paul ^b   Le Dolley, Yvan ^a   Casalta, Jean Paul ^a   Peyrouse, Eric ^a   Prévôt, Sébastien ^a   Thuny, Franck ^a   Collart, Frédéric ^a   Raoult, Didier ^a   Habib, Gilbert ^a   Franceschi, Frédéric ^a  

^a TIMONE HOSPITAL   (France)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; VANCOMYCIN;

AGE DISTRIBUTION; AGED; ANTIMICROBIAL THERAPY; ARTICLE; ARTIFICIAL HEART PACEMAKER; BACTERIAL ENDOCARDITIS; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR EQUIPMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE INFECTION; DEVICE REMOVAL; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REIMPLANTATION; TERTIARY HEALTH CARE; THROMBOCYTOPENIA; TISSUE CULTURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION;

AGED; ANTI-BACTERIAL AGENTS; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ENDOCARDITIS, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84860192436     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-301627     Document Type: Article

References (30)

1. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm Abnormalities: a report of the American College of Cardiology/American heart association Task Force on practice guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and Antiarrhythmia devices): developed in collaboration with the American association for Thoracic surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-408. (Pubitemid 351771339)
2. Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of clinical Microbiology and infectious diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and Cancer. Eur Heart J 2009;30:2369-413.
3. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007;167:669-75. (Pubitemid 46598459)
4. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010;121:458-77.
5. Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol 2010;33:414-19.
6. Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009;6:1085-104.
7. Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133:604-8.
8. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007;49:1851-9. (Pubitemid 46661104)
9. Le Dolley Y, Thuny F, Mancini J, et al. Diagnosis of cardiac device-related infective endocarditis after device removal. JACC Cardiovasc Imaging 2010;3:673-81.
10. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;96:200-9.
11. Sohail MR, Uslan DZ, Khan AH, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc 2008;83:46-53.
12. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005;112:69-75. (Pubitemid 40962571)
13. Franceschi F, Thuny F, Giorgi R, et al. Incidence, risk factors, and outcome of traumatic tricuspid regurgitation after percutaneous ventricular lead removal. J Am Coll Cardiol 2009;53:2168-74.
14. Love CJ, Wilkoff BL, Byrd CL, et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin Electrophysiol 2000;23:544-51.
15. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American heart association Task Force on practice guidelines: endorsed by the Society of cardiovascular Anesthesiologists, Society for cardiovascular Angiography and interventions, and Society of Thoracic Surgeons. Circulation 2008;118:887-96.
16. Baman TS, Gupta SK, Valle JA, et al. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol 2009;2:129-34.
17. Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol 1998;82:480-4. (Pubitemid 28389947)
18. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 1997;95:2098-107. (Pubitemid 27184278)
19. Tarakji KG, Chan EJ, Cantillon DJ, et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm 2010;7:1043-7.
20. Brunner M, Olschewski M, Geibel A, et al. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur Heart J 2004;25:88-95. (Pubitemid 38055597)
21. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
22. Goldenberg I, Gillespie J, Moss AJ, et al. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2010;122:1265-71.
23. Romeyer-Bouchard C, Da Costa A, Dauphinot V, et al. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices. Eur Heart J 2010;31:203-10.
24. Sy RW, Chawantanpipat C, Richmond DR, et al. Thrombocytopenia and mortality in infective endocarditis. J Am Coll Cardiol 2008;51:1824-5. (Pubitemid 351608492)
25. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007;297:1354-61. (Pubitemid 46513236)
26. Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005;293:3012-21. (Pubitemid 40965071)
27. Marijon E, De Guillebon M, Bordachar P, et al. Safety of deferring the reimplantation of pacing systems after their removal for infectious complications in selected patients: a 1-year follow-up study. J Cardiovasc Electrophysiol 2010;21:540-4.
28. Sweeney MO, Hellkamp AS. Heart failure during cardiac pacing. Circulation 2006;113:2082-8.
29. Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol 2009;54:764-76.
30. Braun MU, Rauwolf T, Bock M, et al. Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection - a prospective and controlled study. Pacing Clin Electrophysiol 2006;29:875-9. (Pubitemid 44222141)